lidocaine hci (51662-1419)

Drug Facts

Product Profile

Brand Name lidocaine hci

Generic Name lidocaine hci

Labeler hf acquisition co llc, dba healthfirst

Dosage Form INJECTION, SOLUTION

Routes

INFILTRATION PERINEURAL

Active Ingredients

epinephrine 10 ug/mL, lidocaine hydrochloride 10 mg/mL

Manufacturer

HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1419

Product ID 51662-1419_37b6f90b-34b4-98c1-e063-6394a90a4a74

Product Type HUMAN PRESCRIPTION DRUG

Marketing Category ANDA

Application Number ANDA089644

Listing Expiration 2026-12-31

Marketing Start 2019-10-18

Pharmacologic Class

Established (EPC)

alpha-adrenergic agonist [epc] beta-adrenergic agonist [epc] catecholamine [epc]

Mechanism of Action

adrenergic alpha-agonists [moa] adrenergic beta-agonists [moa]

Chemical Structure

catecholamines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621419

Hyphenated Format 51662-1419

Supplemental Identifiers

RxCUI

1010751

UNII

YKH834O4BH V13007Z41A

NUI

N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name lidocaine hci (source: ndc)

Generic Name lidocaine hci (source: ndc)

Application Number ANDA089644 (source: ndc)

Routes

INFILTRATION PERINEURAL

source: ndc

Resolved Composition

Strengths

10 ug/mL
10 mg/mL

source: ndc

Packaging

30 mL in 1 VIAL, MULTI-DOSE (51662-1419-1)
25 POUCH in 1 CASE (51662-1419-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1419-2) / 30 mL in 1 VIAL, MULTI-DOSE

source: ndc

Packages (2)

51662-1419-1 30 mL in 1 VIAL, MULTI-DOSE (51662-1419-1) 51662-1419-3 25 POUCH in 1 CASE (51662-1419-3) / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1419-2) / 30 mL in 1 VIAL, MULTI-DOSE

Ingredients (2)

epinephrine (10 ug/mL) lidocaine hydrochloride (10 mg/mL)

Linked Drug Pages (1)

LIDOCAINE HCI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload

{"route": ["INFILTRATION", "PERINEURAL"], "spl_id": "37b6f90b-34b4-98c1-e063-6394a90a4a74", "openfda": {"nui": ["N0000000209", "N0000000245", "N0000175552", "N0000175555", "N0000175570", "M0003647"], "unii": ["YKH834O4BH", "V13007Z41A"], "rxcui": ["1010751"], "spl_set_id": ["95309440-34ec-11fe-e053-2a95a90a1c90"], "pharm_class_cs": ["Catecholamines [CS]"], "pharm_class_epc": ["alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]", "Catecholamine [EPC]"], "pharm_class_moa": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, MULTI-DOSE (51662-1419-1)", "package_ndc": "51662-1419-1", "marketing_start_date": "20191018"}, {"sample": false, "description": "25 POUCH in 1 CASE (51662-1419-3)  / 1 VIAL, MULTI-DOSE in 1 POUCH (51662-1419-2)  / 30 mL in 1 VIAL, MULTI-DOSE", "package_ndc": "51662-1419-3", "marketing_start_date": "20230109"}], "brand_name": "LIDOCAINE HCI", "product_id": "51662-1419_37b6f90b-34b4-98c1-e063-6394a90a4a74", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Adrenergic alpha-Agonists [MoA]", "Adrenergic beta-Agonists [MoA]", "Amide Local Anesthetic [EPC]", "Amides [CS]", "Antiarrhythmic [EPC]", "Catecholamine [EPC]", "Catecholamines [CS]", "Local Anesthesia [PE]", "alpha-Adrenergic Agonist [EPC]", "beta-Adrenergic Agonist [EPC]"], "product_ndc": "51662-1419", "generic_name": "LIDOCAINE HCI", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "LIDOCAINE HCI", "active_ingredients": [{"name": "EPINEPHRINE", "strength": "10 ug/mL"}, {"name": "LIDOCAINE HYDROCHLORIDE", "strength": "10 mg/mL"}], "application_number": "ANDA089644", "marketing_category": "ANDA", "marketing_start_date": "20191018", "listing_expiration_date": "20261231"}